Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03061264

Ligand	Ligand name	Chain	PDB	Tanimoto
R23	METHYL-[4-(4-PIPERIDINE-1-YLMETHYL-PHENYL)-CYCLOHEXYL]-CARBAMINIC ACID-(4-CHLOROPHENYL)-ESTER	A,B,C	1O79	0.72
GVB	(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE	A,B	2JID	0.71
IRE	3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY-6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN-4(1H)-YLIDENE]ANILINE	A	2ITZ	0.7
IRE	3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY-6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN-4(1H)-YLIDENE]ANILINE	A	2ITO	0.7
IRE	3-CHLORO-4-FLUORO-N-[(4Z)-7-METHOXY-6-(3-MORPHOLIN-4-YLPROPOXY)QUINAZOLIN-4(1H)-YLIDENE]ANILINE	A	2ITY	0.7
LO2	2-{4-[butyl(3-chloro-4,5-dimethoxybenzyl)amino]phenyl}-1,1,1,3,3,3-hexafluoropropan-2-ol	A,B,C,D	3FAL	0.75
F1N	N-{1-[5-chloro-3-methoxy-2-(1-methylethoxy)benzyl]piperidin-4-yl}-2-(2-methyl-4-sulfamoylphenoxy)acetamide	A	2ZJN	0.72
XNI	(11S)-10-acetyl-11-[4-(benzyloxy)-3-chlorophenyl]-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one	A,B	3CSO	0.71
C5M	N-{(2R,3S)-3-[(3-CHLOROBENZYL)AMINO]-2-HYDROXY-4-PHENYLBUTYL}-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE	B,I	2C8X	0.72
GNT	(-)-GALANTHAMINE	A	1DX6	0.7
GNT	(-)-GALANTHAMINE	A	1QTI	0.7
GNT	(-)-GALANTHAMINE	A,B,C,D,E	2PH9	0.7
GNT	(-)-GALANTHAMINE	A,B	1W76	0.7
GNT	(-)-GALANTHAMINE	A	1W6R	0.7
XX6	2-{[(2R)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE-1,3-DIOL	A	2V3I	0.7
XX7	2-{[(2S)-2-HYDROXY-3-(9-PHENANTHRYLOXY)PROPYL]AMINO}PROPANE-1,3-DIOL	A	2V3R	0.7
SNP	1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL	A	1DY4	0.71
7PC	2-[4-(AMINOMETHYL)-2-CHLOROPHENOXY]-5-PYRIDIN-2-YLPHENOL	A,B	2OP0	0.7
TF3	N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE	A	2BU7	0.75
F1M	N-{1-[5-chloro-3-methoxy-2-(1-methylethoxy)benzyl]piperidin-4-yl}-2-(4-sulfamoylphenoxy)acetamide	A	2ZJM	0.72
A6T	(1S,5R)-7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-N-cyclopropyl-N-(2,3-dichlorobenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide	A,B	3G72	0.71
JPA	4-(2,4-DICHLOROPHENOXY)-2'-METHYLBIPHENYL-3-OL	A,B	2FOI	0.72
REN	(S)-reticuline	A	3FWA	0.79
REN	(S)-reticuline	A	3D2D	0.79
A7T	(1R,5S)-N-cyclopropyl-7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-N-(2,3-dimethylbenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide	A,B	3G6Z	0.77
PTI	2-PHENYL-1-[4-(2-PIPERIDIN-1-YL-ETHOXY)-PHENYL]-1,2,3,4-TETRAHYDRO-ISOQUINOLIN-6-OL	A	1UOM	0.71
A5T	(1R,5S)-7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-N-cyclopropyl-N-(2,3-dichlorobenzyl)-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxamide	A,B	3G70	0.71
DPD		A,B	1QIW	0.84
DPD		A	1QIV	0.84
JPN	2-(2,4-DICHLOROPHENOXY)-5-(3-PHENYLPROPYL)PHENOL	A,B	2OL4	0.7
JPJ	2-(2,4-DICHLOROPHENOXY)-5-(2-PHENYLETHYL)PHENOL	A,B	2OOS	0.7
JPJ	2-(2,4-DICHLOROPHENOXY)-5-(2-PHENYLETHYL)PHENOL	A	3FNH	0.7
C18	7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE	A,B	2V61	0.72
QUM	QUINACRINE MUSTARD	A,B	1GXF	0.7
SLX	(13aS)-3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline-2,9-diol	A	3FW9	0.77